Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 19 (8) , 777-783
- https://doi.org/10.1097/mbc.0b013e32830ef90c
Abstract
To characterize a functional assay for circulating fibrinogen based on rotational thrombelastography. Maximum clot firmness was determined by rotational thrombelastography in normal human plasma pool, fibrinogen-deficient plasma pool, normal whole blood, and individual plasma samples from 17 patients with fibrinogen deficiency. Plasma samples spiked with varying concentrations of exogenous fibrinogen were also measured. Results were compared with enzyme-linked immunosorbent assay and Clauss assay. The impact of sample freezing and filtration and use of cytochalasin D were also investigated. Over the tested range of 0–3 mg/ml added exogenous fibrinogen, the maximum clot firmness standard curve for determination of fibrinogen in plasma pools (n = 7) was linear (r2 = 0.97). Maximum clot firmness was highly linearly correlated both with Clauss assay (r2 = 0.93) and enzyme-linked immunosorbent assay (r2 = 0.95). In unspiked plasma samples from individual patients with fibrinogen deficiency, fibrinogen was undetectable by rotational thromboelastography. By all evaluated methods, the response to spiking with fibrinogen in such samples coincided closely in patients with afibrinogenemia and hypofibrinogenemia. In dysfibrinogenemia, smaller Clauss assay responses to spiking were observed, whereas the enzyme-linked immunosorbent assay response was variable. Maximum clot firmness was the only evaluated method of fibrinogen assessment to yield consistent results across all categories of fibrinogen deficiency. These in-vitro results suggest the potential clinical utility of rotational thromboelastography as a versatile method for monitoring the response to fibrinogen concentrate among patients with fibrinogen deficiency. Clinical investigations using rotational thromboelastography after in-vivo fibrinogen administration to patients with congenital fibrinogen deficiency are warranted.Keywords
This publication has 34 references indexed in Scilit:
- Cost reduction of perioperative coagulation management in cardiac surgery: value of ‘bedside’ thrombelastography (ROTEM)☆European Journal of Cardio-Thoracic Surgery, 2007
- Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effectsActa Anaesthesiologica Scandinavica, 2007
- Retrochorionic hematoma in congenital afibrinogenemia: Resolution with fibrinogen concentrate infusionsAmerican Journal of Hematology, 2007
- Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastographyHaemophilia, 2006
- Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian groupBlood Coagulation & Fibrinolysis, 2006
- Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?Interactive CardioVascular and Thoracic Surgery, 2005
- Pharmacokinetic properties of a pasteurised fibrinogen concentrateTransfusion and Apheresis Science, 2005
- Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiencyTransfusion and Apheresis Science, 2005
- Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography®: critical roles of fibrinogen and factors II, VII, X and XIIActa Anaesthesiologica Scandinavica, 2005
- Evaluation of the Contribution of Platelets to Clot Strength by Thromboelastography in Rabbits: The Role of Tissue Factor and Cytochalasin DAnesthesia & Analgesia, 2000